awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33275887-332DB2A0-0647-429F-BD81-04A42995D56E
Q33275887-332DB2A0-0647-429F-BD81-04A42995D56E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33275887-332DB2A0-0647-429F-BD81-04A42995D56E
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.
P2860
Q33275887-332DB2A0-0647-429F-BD81-04A42995D56E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33275887-332DB2A0-0647-429F-BD81-04A42995D56E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
363ba674c827d21344f1d2be13f31dc8bef2ba88
P2860
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.